Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

DnaJC14 Inhibitors

DNAJC14 inhibitors constitute a distinctive class of chemical compounds designed to exert control over the activity of the DNAJC14 protein, a member of the DnaJ heat shock protein family (Hsp40). The primary objective of these inhibitors is to selectively interfere with the functions and interactions of DNAJC14 within the intricate landscape of cellular processes. DNAJC14, known for its involvement in protein folding, quality surveillance, and intracellular trafficking, serves as a co-chaperone that collaborates with molecular chaperones to facilitate the proper conformational maturation of diverse client proteins. The rational design and development of DNAJC14 inhibitors stem from an in-depth comprehension of the protein's pivotal role in cellular biology. By disrupting DNAJC14-mediated interactions, these inhibitors exert downstream effects on a plethora of molecular pathways. This interference may influence the folding and assembly of client proteins, potentially leading to aberrant downstream signaling, misfolded protein accumulation, or altered cellular trafficking. The creation of effective DNAJC14 inhibitors necessitates a nuanced approach to ensure both specificity and potency. It involves meticulous exploration of the structural characteristics of DNAJC14 and its binding partners, aiming to identify key binding sites that can be selectively targeted. Subsequently, these compounds are strategically tailored to interact with these sites, either competitively or allosterically, in order to impede the normal functions of DNAJC14. Research into DNAJC14 inhibitors serves as a window into the complex web of molecular interactions that underlie fundamental cellular processes. The insights gained from these studies extend beyond the realm of DNAJC14 itself, offering a broader understanding of the delicate balance and coordination required for proper cellular function. While these inhibitors hold promise for potential applications in various contexts, including research and biotechnology, it's important to note that their development and implications remain an active area of scientific investigation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ramelteon

196597-26-9sc-219934
1 mg
$190.00
3
(1)

DNAJC14 inhibitor; mechanism involves disruption of DNAJC14-mediated processes.

Galanthamine

357-70-0sc-218556
10 mg
$320.00
(0)

Modulates DNAJC14 function, affecting its interaction with target molecules.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Inhibits Hsp90, indirectly impacting DNAJC14-mediated protein folding.

Radicicol

12772-57-5sc-200620
sc-200620A
1 mg
5 mg
$90.00
$326.00
13
(1)

Disrupts Hsp90 activity, leading to downstream effects on DNAJC14 pathways.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$66.00
$153.00
16
(2)

Hsp90 inhibitor, potentially influencing DNAJC14-associated processes.

Novobiocin

303-81-1sc-362034
sc-362034A
5 mg
25 mg
$96.00
$355.00
(0)

Inhibits Hsp90 and could indirectly affect DNAJC14-mediated activities.

NVP-AUY922

747412-49-3sc-364551
sc-364551A
sc-364551B
sc-364551C
sc-364551D
sc-364551E
5 mg
25 mg
100 mg
250 mg
1 g
5 g
$150.00
$263.00
$726.00
$1400.00
$2900.00
$11000.00
3
(1)

Hsp90 inhibitor, possibly influencing DNAJC14-associated pathways.

BIIB 021

848695-25-0sc-364434
sc-364434A
5 mg
25 mg
$128.00
$650.00
(0)

Disrupts Hsp90, which might have downstream effects on DNAJC14 processes.

AT13387

912999-49-6sc-364415
sc-364415A
10 mg
50 mg
$555.00
$1606.00
(0)

Hsp90 inhibitor, possibly affecting cellular processes involving DNAJC14.

IPI-504

857402-63-2sc-364512
sc-364512A
10 mg
50 mg
$640.00
$1600.00
(0)

Modulates Hsp90, potentially influencing DNAJC14-related cellular activities.